Time filter

Source Type

Brunner P.M.,Center for Biomolecular Medicine and Pharmacology | Heier P.C.,Center for Biomolecular Medicine and Pharmacology | Mihaly-Bison J.,Center for Biomolecular Medicine and Pharmacology | Priglinger U.,Center for Biomolecular Medicine and Pharmacology | And 3 more authors.
Blood | Year: 2011

VEGF 165, the major angiogenic growth factor, is known to activate various steps in proangiogenic endothelial cell behavior, such as endothelial cell migration and invasion, or endothelial cell survival. Thereby, the urokinase-type plasminogen activator (uPA) system has been shown to play an essential role not only by its proteolytic capacities, but also by induction of intracellular signal transduction. Therefore, expression of its cell surface receptor uPAR is thought to be an essential regulatory mechanism in angiogenesis. We found that uPAR expression on the surface of confluent endothelial cells was down-regulated compared with subconfluent proliferating endothelial cells. Regulation of uPAR expression was most probably affected by extracellular signalregulated kinase 1/2 (ERK1/2) activation, a downstream signaling event of the VEGF/VEGF-receptor system. Consistently, the receptor-like protein tyrosine phosphatase DEP-1 (density enhanced phosphatase-1/CD148), which is abundantly expressed in confluent endothelial cells, inhibited the VEGF-dependent activation of ERK1/2, leading to downregulation of uPAR expression. Overexpression of active ERK1 rescued the DEP-1 effect on uPAR. That DEP-1 plays a biologic role in angiogenic endothelial cell behavior was demonstrated in endothelial cell migration, proliferation, and capillary-like tube formation assays in vitro. © 2011 by The American Society of Hematology.

Loading Center for Biomolecular Medicine and Pharmacology collaborators
Loading Center for Biomolecular Medicine and Pharmacology collaborators